XPERI INC (XPER) Stock Fundamental Analysis

NYSE:XPER • US98423J1016

6.13 USD
+0.35 (+6.06%)
At close: Feb 27, 2026
6.1 USD
-0.03 (-0.49%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Taking everything into account, XPER scores 3 out of 10 in our fundamental rating. XPER was compared to 276 industry peers in the Software industry. While XPER seems to be doing ok healthwise, there are quite some concerns on its profitability. XPER is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year XPER was profitable.
  • XPER had a negative operating cash flow in the past year.
  • In the past 5 years XPER always reported negative net income.
  • XPER had negative operating cash flow in 4 of the past 5 years.
XPER Yearly Net Income VS EBIT VS OCF VS FCFXPER Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

  • XPER has a better Return On Assets (1.11%) than 61.96% of its industry peers.
  • XPER has a Return On Equity of 1.65%. This is in the better half of the industry: XPER outperforms 62.32% of its industry peers.
Industry RankSector Rank
ROA 1.11%
ROE 1.65%
ROIC N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
XPER Yearly ROA, ROE, ROICXPER Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • XPER has a Profit Margin of 1.53%. This is in the better half of the industry: XPER outperforms 61.59% of its industry peers.
  • The Gross Margin of XPER (73.61%) is better than 60.14% of its industry peers.
  • XPER's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.53%
GM 73.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
XPER Yearly Profit, Operating, Gross MarginsXPER Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • XPER does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for XPER. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
XPER Yearly Shares OutstandingXPER Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
XPER Yearly Total Debt VS Total AssetsXPER Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • XPER has an Altman-Z score of -0.33. This is a bad value and indicates that XPER is not financially healthy and even has some risk of bankruptcy.
  • XPER's Altman-Z score of -0.33 is on the low side compared to the rest of the industry. XPER is outperformed by 72.46% of its industry peers.
  • XPER has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • XPER has a Debt to Equity ratio of 0.10. This is comparable to the rest of the industry: XPER outperforms 53.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z -0.33
ROIC/WACCN/A
WACC10.8%
XPER Yearly LT Debt VS Equity VS FCFXPER Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • XPER has a Current Ratio of 2.42. This indicates that XPER is financially healthy and has no problem in meeting its short term obligations.
  • XPER's Current ratio of 2.42 is fine compared to the rest of the industry. XPER outperforms 66.67% of its industry peers.
  • A Quick Ratio of 2.42 indicates that XPER has no problem at all paying its short term obligations.
  • XPER has a better Quick ratio (2.42) than 67.39% of its industry peers.
Industry RankSector Rank
Current Ratio 2.42
Quick Ratio 2.42
XPER Yearly Current Assets VS Current LiabilitesXPER Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for XPER have decreased strongly by -18.56% in the last year.
  • XPER shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -26.53% yearly.
EPS 1Y (TTM)-18.56%
EPS 3YN/A
EPS 5Y-26.53%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.78%

3.2 Future

  • Based on estimates for the next years, XPER will show a very strong growth in Earnings Per Share. The EPS will grow by 41.01% on average per year.
  • XPER is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.64% yearly.
EPS Next Y26.73%
EPS Next 2Y41.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.69%
Revenue Next 2Y8.88%
Revenue Next 3Y11.61%
Revenue Next 5Y11.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XPER Yearly Revenue VS EstimatesXPER Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
XPER Yearly EPS VS EstimatesXPER Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • XPER is valuated cheaply with a Price/Earnings ratio of 7.76.
  • XPER's Price/Earnings ratio is rather cheap when compared to the industry. XPER is cheaper than 92.39% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.07. XPER is valued rather cheaply when compared to this.
  • XPER is valuated cheaply with a Price/Forward Earnings ratio of 6.12.
  • 92.75% of the companies in the same industry are more expensive than XPER, based on the Price/Forward Earnings ratio.
  • XPER is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.76
Fwd PE 6.12
XPER Price Earnings VS Forward Price EarningsXPER Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • XPER's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. XPER is cheaper than 68.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.69
XPER Per share dataXPER EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • XPER's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as XPER's earnings are expected to grow with 41.01% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y41.01%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • XPER does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XPERI INC

NYSE:XPER (2/27/2026, 8:04:00 PM)

After market: 6.1 -0.03 (-0.49%)

6.13

+0.35 (+6.06%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-25
Earnings (Next)N/A
Inst Owners90.98%
Inst Owner Change-0.12%
Ins Owners3.01%
Ins Owner Change-0.54%
Market Cap284.06M
Revenue(TTM)N/A
Net Income(TTM)6.96M
Analysts81.82
Price Target11.63 (89.72%)
Short Float %5.76%
Short Ratio6.31
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.63%
Min EPS beat(2)13.91%
Max EPS beat(2)31.34%
EPS beat(4)4
Avg EPS beat(4)180.36%
Min EPS beat(4)13.91%
Max EPS beat(4)613.01%
EPS beat(8)8
Avg EPS beat(8)191.78%
EPS beat(12)12
Avg EPS beat(12)151.91%
EPS beat(16)15
Avg EPS beat(16)118.82%
Revenue beat(2)1
Avg Revenue beat(2)-3.76%
Min Revenue beat(2)-8.36%
Max Revenue beat(2)0.84%
Revenue beat(4)1
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-8.36%
Max Revenue beat(4)0.84%
Revenue beat(8)1
Avg Revenue beat(8)-3.05%
Revenue beat(12)2
Avg Revenue beat(12)-2.4%
Revenue beat(16)2
Avg Revenue beat(16)-10.95%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.77%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 7.76
Fwd PE 6.12
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB 1
EV/EBITDA 27.69
EPS(TTM)0.79
EY12.89%
EPS(NY)1
Fwd EY16.33%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS9.8
BVpS9.09
TBVpS6.13
PEG (NY)0.29
PEG (5Y)N/A
Graham Number12.71
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 1.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.53%
GM 73.61%
FCFM N/A
ROA(3y)-41.72%
ROA(5y)-29.98%
ROE(3y)-66.84%
ROE(5y)-46.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5Y-4.34%
F-Score4
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA 4.87
Cap/Depr 37.93%
Cap/Sales 4.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.42
Quick Ratio 2.42
Altman-Z -0.33
F-Score4
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)21.67%
Cap/Depr(5y)15.65%
Cap/Sales(3y)2.93%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.56%
EPS 3YN/A
EPS 5Y-26.53%
EPS Q2Q%-38.46%
EPS Next Y26.73%
EPS Next 2Y41.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.78%
Revenue Next Year5.69%
Revenue Next 2Y8.88%
Revenue Next 3Y11.61%
Revenue Next 5Y11.64%
EBIT growth 1Y59.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year631.37%
EBIT Next 3Y119.05%
EBIT Next 5Y75.21%
FCF growth 1Y56.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.02%
OCF growth 3YN/A
OCF growth 5YN/A

XPERI INC / XPER FAQ

What is the fundamental rating for XPER stock?

ChartMill assigns a fundamental rating of 3 / 10 to XPER.


What is the valuation status of XPERI INC (XPER) stock?

ChartMill assigns a valuation rating of 7 / 10 to XPERI INC (XPER). This can be considered as Undervalued.


What is the profitability of XPER stock?

XPERI INC (XPER) has a profitability rating of 2 / 10.


How financially healthy is XPERI INC?

The financial health rating of XPERI INC (XPER) is 4 / 10.


Is the dividend of XPERI INC sustainable?

The dividend rating of XPERI INC (XPER) is 0 / 10 and the dividend payout ratio is 0%.